Results 21 to 30 of about 368,924 (355)
Intraductal Carcinoma of the Prostate
Intraductal carcinoma of the prostate (IDC-P) is characterized by malignant cells expanding the lumen of prostatic ducts and acini (Figure 1) (1). The basal cells are completely or partially preserved (Figure 2).
Kutsal Yörükoğlu
doaj +1 more source
Urethral carcinoma: A compilation of case studies and research findings
There are three major recognized histological types for primary urethral carcinoma (PUC). These include transitional cell carcinoma (55%), squamous cell carcinoma (21.5%), and adenocarcinoma (16.4%).
Cheau Williams, MD, FACOG, FACS +2 more
doaj +1 more source
Grading and Study of Biological Markers in Ductal Carcinoma in situ and Concurrent Infiltrating Ductal Carcinoma of Breast [PDF]
Introduction: Breast cancer is the most common cancer in women. Breast cancer has surpassed cervical cancer and is now the leading cause of cancer death; however, cervical cancer still remains common in rural areas.
Lovely George, Muktha Ramesh Pai
doaj +1 more source
Herpetic Esophagitis Mimicking Carcinoma In Situ
Herpes Simplex virus (HSV) type I is a common infectious agent of nongenital areas and has been diagnosed most frequently in esophagitis even in otherwise healthy subjects.
Luiz Cesar Peres +4 more
doaj +1 more source
Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery [PDF]
Objective: The aim of this study was to externally validate the prognostic value of concomitant urothelial carcinoma in situ (CIS) in radical cystectomy (RC) specimens using a large international cohort of bladder cancer patients. Methods: The records of
Colin P. Dinney +26 more
core +1 more source
Diagnosis and Treatment of Three Cases of Bronchial Carcinoma In Situ
As part of a retrospective study on bronchoscopies performed at the Clinic of Pneumonology and Phthisiatry of the University Hospital – Pleven by autofluorescence bronchoscopy we found 3 cases diagnosed with carcinoma in situ.
Andreev Valeri Y. +7 more
doaj +1 more source
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
Ductal carcinoma in situ (DCIS), especially in the era of mammographic screening, is a commonly diagnosed breast tumor. Despite the low breast cancer mortality risk, management with breast conserving surgery (BCS) and radiotherapy (RT) is the prevailing ...
Ezra Hahn +6 more
doaj +1 more source
Breast Ductal Carcinoma In Situ [PDF]
Ductal carcinoma in situ (DCIS) of the breast is becoming one of the most important diseases diagnosed in preventive medicine screening. The current age-adjusted incidence rate of DCIS is 32.5 per 100,000 women. For women 50–64 years of age, the incidence is approximately 88 per 100,000. Currently, for every 4 diagnoses of invasive breast cancer, there
V. Sacchini +5 more
openaire +2 more sources
Clinical-pathological features of an occult mixed mucinous male breast cancer. a case report [PDF]
Mucinous carcinoma of the male breast is an uncommon malignant breast neoplasm and its diagnoses remain difficult. It is probably due to such a low rate of breast cancer cases that men tend to be diagnosed at an older age than women and with a later ...
Bonifacino, Adriana +7 more
core +1 more source
Introducción: el cáncer de piel representa un problema de salud pública que se puede prevenir y manejar con éxito ante el diagnóstico temprano. Objetivo: describir las características clínicas, histopatológicas, poblacionales y quirúrgicas del cáncer de ...
Oscar Mora H. +3 more
doaj +1 more source

